The global bionic eye market was valued at USD 319.59 Million in 2025. The market is expected to grow at a CAGR of 11.24% during the forecast period of 2026-2035, with the values likely to reach USD 927.26 Million by 2035. The market growth is driven by increasing advancements in neuroprosthetic technologies and the growing prevalence of vision disorders. Expanding research funding, supportive regulatory approvals, and rising adoption of implantable vision restoration devices are boosting growth. Continuous innovation in artificial intelligence integration and retinal microchip design is expected to accelerate market expansion during the forecast period.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
11.24%
Value in USD Million
2026-2035
*this image is indicative*
Bionic eyes, or visual prostheses, are tools to help people with serious vision problems see again. The rise in retinal diseases, technological advancements, and the need for new treatments are driving the market growth. These devices work around impaired photoreceptors in the retina by activating unaffected cells to send visual signals to the brain.
Rising Incidence of Visual Impairment Boosts Market Growth
The World Health Organization reports that around 2.2 billion people are affected by either near or distant vision problems. The market is rapidly expanding due to the increasing incidence of visual impairment and blindness, with global factors being age-related macular degeneration (AMD), retinitis pigmentosa, and diabetic retinopathy. AMD affects central vision in the elderly, leading to a gradual decline, while retinitis pigmentosa also results in a progressive reduction in vision. As cases rise, there is a growing demand for advanced solutions such as bionic eyes, leading to market expansion.
Growing Aging Population Drives the Market Growth
The elderly are more susceptible to age-associated eye pathologies such as macular degeneration and retinitis pigmentosa, resulting in blindness or significantly reduced vision. Bionic eye technology makes it possible to help such individuals regain vision. With the increasing proportion of elderly people around the world, the demand for bionic eyes will increase, thereby fuelling market growth in the forecast period.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
In February 2023, NIDEK CO., LTD. signed a strategic partnership agreement with HOYA Vision Care, the world’s leading company in optical technology, to offer products and instruments to eye care professionals (ECPs). The strategic alignment focuses on an improved experience, patients’ well-being, and advanced eye care, along with superior solutions that would improve their quality of life.
The Expert Market Research’s report titled “Global Bionic Eye Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Technology
Market Breakup by Indication
Market Breakup by End User
Market Breakup by Region
Electronic Bionic Eye Segment is Anticipated Substantial Growth in the Market Segmentation Based on Technology
Based on the application the market is segmented into mechanical, and electronic bionic eyes. Among these, the electronic bionic eye is expected to dominate the market as it uses microelectrode array technology to stimulate healthy retinal cells or the visual cortex to offer artificial vision with functionality. The development in electrodes and implantable electronics is increasing the performance of these devices and miniaturizing them for better integration with the eye.
Market Segmentation Based on Indication Set to Witness Substantial Growth
Based on the indication, the market is divided into vision loss and impairment, dry age-related macular degeneration (dry AMD), and others. Among these, the vision loss and impairment market is projected to lead to bionic eye systems for people with visual disorders. These solutions assist in regaining or boosting vision, hence having the potential to make patient lives better.
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America is expected to dominate the market due to the presence of several prominent market players, enhanced healthcare facilities, and greater healthcare spending. This region’s market growth rate has been enhanced through the contributions of the United States and Canada.
The Asia-Pacific region is expected to show rapid growth rate in the forecast period. The growth can be attributed to an increased focus on regional factors such as growing healthcare costs, developing healthcare facilities, and a high patient population.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
The company was established in 2009 and is in Melbourne, Australia. Bionic Vision Technologies is developing retinal implants for retinitis pigmentosa patients, with their flagship product, BVT Bionic Eye, undergoing clinical trials for functional vision.
The company was founded in 2011 and is in Paris, France. PIXIUM VISION develops cutting-edge bionic vision systems such as PRIMA, designed for patients with severe vision loss, with a specific focus on sub-retinal implants for dry age-related macular degeneration.
Established in 2012 and headquartered in California, USA, Vivani Medical, Inc., creates cutting-edge neural interface systems like the Argus II Retinal Prosthesis System to help patients with severe retinitis pigmentosa by offering electrical stimulation to restore vision.
Based in Australia and established in 2009, Monash Vision Group, spearheaded by Monash University, is working on the Gennaris Bionic Vision System. It is a cortical implant designed to stimulate the visual cortex by bypassing impaired retinas.
Founded in 2016 and headquartered in Canada, iBIONICS creates advanced retinal implants for diseases such as AMD. Their top products include Diamond Eye, which enhances visual experience by activating healthy retinal cells.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Kindly note that this only represents a partial list of companies, and the complete list has been in the report.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Technology |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share